Trexquant Investment’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-398,751
| Closed | -$2.5M | – | 1796 |
|
|
2025
Q1 | $2.5M | Buy |
398,751
+20,114
| +5% | +$126K | 0.03% | 788 |
|
|
2024
Q4 | $3.07M | Buy |
+378,637
| New | +$3.07M | 0.04% | 698 |
|
|
2023
Q4 | – | Sell |
-58,825
| Closed | -$610K | – | 1708 |
|
|
2023
Q3 | $610K | Buy |
58,825
+40,524
| +221% | +$420K | 0.02% | 933 |
|
|
2023
Q2 | $262K | Buy |
+18,301
| New | +$262K | 0.01% | 1237 |
|
|
2022
Q4 | – | Sell |
-14,955
| Closed | -$166K | – | 1650 |
|
|
2022
Q3 | $166K | Sell |
14,955
-18,388
| -55% | -$204K | 0.01% | 1230 |
|
|
2022
Q2 | $281K | Buy |
+33,343
| New | +$281K | 0.01% | 1161 |
|
|
2021
Q1 | – | Sell |
-6,262
| Closed | -$208K | – | 1386 |
|
|
2020
Q4 | $208K | Buy |
+6,262
| New | +$208K | 0.02% | 872 |
|